Pediatrix Medical (MD) Net Equity Issued and Repurchased (2009 - 2026)

Pediatrix Medical (MD) has reported Net Equity Issued and Repurchased for 18 consecutive years, with $544000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Equity Issued and Repurchased fell 17.82% year-over-year to $544000.0; the TTM figure through Mar 2026 stood at $3.1 million (down 10.87% YoY), while the FY2025 annual figure was $3.2 million, down 12.48% from the prior year.
• Net Equity Issued and Repurchased declined to $544000.0 in Q1 2026 per MD's latest filing, from $646000.0 in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $1.7 million in Q2 2022 and bottomed at $544000.0 in Q1 2026.
• Historically, Net Equity Issued and Repurchased has averaged $1.0 million across 5 years, with a median of $1.1 million in 2023.
• On a YoY basis, Net Equity Issued and Repurchased climbed as much as 12.67% in 2022 and fell as far as 54.43% in 2022.
• Pediatrix Medical's Net Equity Issued and Repurchased stood at $1.2 million in 2022, then fell by 11.9% to $1.0 million in 2023, then declined by 29.34% to $732000.0 in 2024, then slipped by 11.75% to $646000.0 in 2025, then slipped by 15.79% to $544000.0 in 2026.
• Business Quant data shows MD's Net Equity Issued and Repurchased at $544000.0 in Q1 2026, $646000.0 in Q4 2025, and $700000.0 in Q3 2025.